Atlas Trials

Study to Investigate the Immune Response to Two Doses of VAX102 Healthy Adults

Clinical trial NCT00921206 · COMPLETED

Trial details

NCT number
NCT00921206
Sponsor
VaxInnate Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Influenza
Start date
2009-06-01
Primary completion
2009-10-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.